Which statement correctly describes buprenorphine's pharmacology?

• A. Buprenorphine is a partial mu-opioid receptor agonist with a ceiling effect.
• B. Buprenorphine is a full agonist.
• C. Buprenorphine is an antagonist.
• D. Buprenorphine is a non-opioid analgesic.

Answer: (A)

Buprenorphine acts as a partial mu-opioid receptor agonist. That means it activates these receptors but to a lesser maximal effect than a full opioid agonist like morphine. Because of this partial activation, there’s a ceiling effect: after a certain dose, increasing buprenorphine doesn’t produce greater effects on things like respiratory depression or euphoria. This property lowers overdose risk and helps explain its safer profile in opioid use disorder treatment. Its high receptor affinity and slow dissociation also let it block other opioids from binding, reinforcing its use in maintenance therapy. It isn’t a full agonist, it isn’t an antagonist, and it is an opioid, not a non-opioid analgesic.